Analysts Set Bausch + Lomb Corporation (NYSE:BLCO) PT at $18.75

Bausch + Lomb Corporation (NYSE:BLCO) has been assigned a consensus rating of “Hold” from the thirteen analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $18.75.

A number of equities analysts have commented on BLCO shares. Citigroup boosted their target price on shares of Bausch + Lomb from $19.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. Evercore set a $17.00 price objective on shares of Bausch + Lomb in a research report on Monday, July 6th. Weiss Ratings raised shares of Bausch + Lomb from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. UBS Group began coverage on shares of Bausch + Lomb in a research note on Thursday, July 30th. They set a “buy” rating and a $21.00 price objective for the company. Finally, HC Wainwright reissued a “buy” rating and set a $21.00 target price on shares of Bausch + Lomb in a research report on Friday.

Bausch + Lomb Stock Down 0.1%

Shares of NYSE BLCO opened at $17.13 on Friday. The company has a current ratio of 1.55, a quick ratio of 1.02 and a debt-to-equity ratio of 0.79. The stock has a market capitalization of $6.12 billion, a PE ratio of -35.69, a price-to-earnings-growth ratio of 0.54 and a beta of 0.55. The stock’s fifty day simple moving average is $16.61 and its two-hundred day simple moving average is $16.43. Bausch + Lomb has a 12-month low of $13.77 and a 12-month high of $18.92.

Bausch + Lomb (NYSE:BLCO) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.01). The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.37 billion. Bausch + Lomb had a positive return on equity of 4.14% and a negative net margin of 3.21%.The company’s revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.18) earnings per share. As a group, analysts expect that Bausch + Lomb will post 0.81 EPS for the current fiscal year.

Insiders Place Their Bets

In other Bausch + Lomb news, CAO Frederick Munsch sold 52,900 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $16.78, for a total transaction of $887,662.00. Following the sale, the chief accounting officer owned 45,831 shares of the company’s stock, valued at approximately $769,044.18. The trade was a 53.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Eschenbach Andrew C. Von sold 6,059 shares of the company’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $16.58, for a total value of $100,458.22. Following the completion of the transaction, the director directly owned 63,733 shares in the company, valued at approximately $1,056,693.14. The trade was a 8.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 71,459 shares of company stock valued at $1,194,370 in the last three months. Insiders own 1.45% of the company’s stock.

Hedge Funds Weigh In On Bausch + Lomb

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. grew its position in Bausch + Lomb by 729.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,322 shares of the company’s stock worth $30,000 after purchasing an additional 2,042 shares during the period. Caitong International Asset Management Co. Ltd raised its holdings in Bausch + Lomb by 104.1% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,227 shares of the company’s stock worth $38,000 after purchasing an additional 1,136 shares during the period. Royal Bank of Canada raised its holdings in Bausch + Lomb by 67.1% in the 1st quarter. Royal Bank of Canada now owns 3,657 shares of the company’s stock worth $58,000 after purchasing an additional 1,468 shares during the period. Wells Fargo & Company MN boosted its position in Bausch + Lomb by 31.2% during the fourth quarter. Wells Fargo & Company MN now owns 5,903 shares of the company’s stock worth $101,000 after purchasing an additional 1,403 shares in the last quarter. Finally, Focus Partners Wealth purchased a new position in Bausch + Lomb during the third quarter worth approximately $170,000. Institutional investors and hedge funds own 11.07% of the company’s stock.

Bausch + Lomb Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.